v3.26.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Stock Payable
Accumulated Deficit
Receivable Related to Employee Equity Awards
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Balance at Dec. 31, 2023 $ 5,658,989 $ 1 $ 97,583,906 $ 5,233 $ (91,930,152)   $ 1 $ 0
Balance (in Shares) at Dec. 31, 2023   5,937         141.397  
Preferred Stock conversion To Common Stock 0 $ 0 1 0 0   $ (1) 0
Preferred Stock conversion To Common Stock (in Shares)   5         (123.909)  
Common stock issued for cash 1,148,470 $ 0 1,148,470 0 0   $ 0 0
Common stock issued for cash (in Shares)   3,671            
Common Stock issued for Warrant Exercise 5,368,364 $ 52 5,368,312 0 0   0 0
Common Stock issued for Warrant Exercise (in Shares)   520,922            
Common Stock issued for Cashless Warrant Exercise 1,320,567 $ 0 1,320,567 0 0   0  
Common Stock issued for Cashless Warrant Exercise (in Shares)   6,327            
Fair value of vested Common Stock 80,000 $ 0 80,000 0 0   0 0
Fair value of vested stock options (in Shares)   46            
Fair value of vested stock options 491,924 $ 0 491,924 0 0   0 0
Stock Payable Towards preference Dividend 0 0 5,233 (5,233) 0   0  
Net Income (Loss) (11,507,947) 0 0 0 (11,507,947)   0 0
Balance at Dec. 31, 2024 2,560,366 $ 53 105,998,412 0 (103,438,099)   $ 0 $ 0
Balance (in Shares) at Dec. 31, 2024   536,908         17.488 0
Common stock issued for cash 1,003,218 $ 21 1,003,197   0   $ 0 $ 0
Common stock issued for cash (in Shares)   215,482            
Fair value of vested stock options 132,279 $ 0 132,279   0   0 0
Fair value of vested restricted stock units 39,530 0 39,530   0   0 0
Net Income (Loss) (2,262,242) 0 0   (2,262,242)   0 0
Balance at Jun. 30, 2025 1,473,151 $ 74 107,173,418   (105,700,341)   $ 0 $ 0
Balance (in Shares) at Jun. 30, 2025   752,390         17.488 0
Balance at Dec. 31, 2024 2,560,366 $ 53 105,998,412 0 (103,438,099)   $ 0 $ 0
Balance (in Shares) at Dec. 31, 2024   536,908         17.488 0
Common stock issued for cash 1,218,244 $ 26 1,218,218 0 0   $ 0 $ 0
Common stock issued for cash (in Shares)   260,030            
Common stock issued for fundraising 4,514,481 $ 37 4,514,444 0 0   0 0
Common stock issued for fundraising (in Shares)   379,539            
Fair value of vested advisory warrant 665,030 $ 0 665,030 0 0   0 0
Fair value of vested stock options 143,122 0 143,122 0 0   0 0
Fair value of vested restricted stock awards 186,287 0 186,287 0 0   0 0
Net Income (Loss) (7,027,410) 0 0 0 (7,027,410)   0 0
Balance at Dec. 31, 2025 2,260,120 $ 116 112,725,513 0 (110,465,509) $ 0 $ 0 $ 0
Balance (in Shares) at Dec. 31, 2025   1,176,477         17.488 0
Balance at Mar. 31, 2025 1,752,885 $ 55 106,227,259   (104,474,429)   $ 0 $ 0
Balance (in Shares) at Mar. 31, 2025   562,213         17.488 0
Common stock issued for cash 857,415 $ 19 857,396   0   $ 0 $ 0
Common stock issued for cash (in Shares)   190,177            
Fair value of vested stock options 49,233 $ 0 49,233   0   0 0
Fair value of vested restricted stock units 39,530 0 39,530   0   0 0
Net Income (Loss) (1,225,912) 0 0   (1,225,912)   0 0
Balance at Jun. 30, 2025 1,473,151 $ 74 107,173,418   (105,700,341)   $ 0 $ 0
Balance (in Shares) at Jun. 30, 2025   752,390         17.488 0
Balance at Dec. 31, 2025 2,260,120 $ 116 112,725,513 $ 0 (110,465,509) 0 $ 0 $ 0
Balance (in Shares) at Dec. 31, 2025   1,176,477         17.488 0
Common stock issued for cash 357,684 $ 8 357,676   0 0 $ 0 $ 0
Common stock issued for cash (in Shares)   82,174            
Fair value of vested stock options 8,292 $ 0 8,292   0 0 0 0
Common stock issued for cash - private fundraising 158,013 $ 6 158,007          
Common stock issued for cash - private fundraising (in Shares)   66,846            
Fair value allocated to warrants during fundraising 2,432,783 $ 0 2,432,783   0 0 0 0
Fair value allocated to prefunded warrants during fundraising 1,209,206 0 1,209,206   0 0 $ 0 $ 0
Fair value of vested restricted stock awards 101,175 $ 3 101,172   0 0    
Fair value of vested restricted stock awards (in Shares)   29,326         0 0
Fair value of vested restricted stock units 933,907 $ 15 1,006,873   0 (72,981)    
Fair value of vested restricted stock units (in Shares)   145,015         0 0
Net Income (Loss) (1,151,489) $ 0 0   (1,151,489) 0 $ 0 $ 0
Balance at Jun. 30, 2026 6,309,691 $ 148 117,999,522   (111,616,998) (72,981) $ 0 $ 0
Balance (in Shares) at Jun. 30, 2026   1,499,838         17.488 0
Balance at Mar. 31, 2026 1,786,885 $ 122 113,563,705   (111,776,942) 0 $ 0 $ 0
Balance (in Shares) at Mar. 31, 2026   1,240,751         17.488 0
Common stock issued for cash 93,936 $ 2 93,934   0 0 $ 0 $ 0
Common stock issued for cash (in Shares)   17,900            
Fair value of vested stock options 384 $ 0 384   0 0 0 0
Common stock issued for cash - private fundraising 158,013 $ 6 158,007   0   0 0
Common stock issued for cash - private fundraising (in Shares)   66,846            
Fair value allocated to warrants during fundraising 2,432,783 $ 0 2,432,783   0 0 0  
Fair value allocated to prefunded warrants during fundraising 1,209,206 0 1,209,206   0 0 0 0
Fair value of vested restricted stock awards 70,588 $ 3 70,585     0 0 0
Fair value of vested restricted stock awards (in Shares)   29,326            
Fair value of vested restricted stock units 397,952 $ 15 470,918   0 (72,981) 0 0
Fair value of vested restricted stock units (in Shares)   145,015            
Net Income (Loss) 159,944 $ 0 0   159,944 0 0 0
Balance at Jun. 30, 2026 $ 6,309,691 $ 148 $ 117,999,522   $ (111,616,998) $ (72,981) $ 0 $ 0
Balance (in Shares) at Jun. 30, 2026   1,499,838         17.488 0